October October
If there is one particular month to deploy cash this would be the month. The SRS Fund was not spared as the traditional blood-letting month lived up to its name bringing the SRS fund back into slight negative territory for the year.
The SRS Fund is down 1.15% year to date versus the STI negative 5.64%. While the fund held onto its lead against the index there is little to celebrate as long-term yield spike during the month threatening to normalise the yield curve.
It was only after the Federal Reserves signaled the likely end to rate hikes that gave much comfort to the market as yields pulled back from their all-time highs. As such, the market began to rally shortly into November with all yield-sensitive stocks like REITs making a strong rebound.
There are however no activities for the SRS Funds in October despite the amount of blood on the street as I aim to start building a reasonable cash buffer for the fund while interest rates remains elevated.
Portfolio Segments
Portfolio allocation remains heavy in the finance sector as the outlook on banks remains much brighter than most other segments. Going forward however cash resources will be allocated towards non finance sector due to this overweighting.
Dividends
A mere $255 of dividend was received in October from SGX. However, I would expect a record Q4 dividend judging by up and coming announced dividends.
SRS Fund Value
The SRS Fund value plummeted to $353,052.28 in the month making this pullback one of the steepest for the fund in the last 5 years.
Cash Levels
Cash level should continue to rise as I start to build up a significant cash buffer with a yield in the range of 4%. My initial cash target for the SRS Fund would be in the region of 10% for cash if no good opportunity arises.
Many investors will be relieved by the sudden change in yield pressure however, I do not see any upcoming interest rate cut anytime soon. Sure inflation should come down somewhat but one should not expect rates to go back down to ultra-low levels like what we have seen in the past 2 decades.
-
The SRS Fund Jul 2026
For much of 2026, the market’s attention has been firmly fixed on AI, semiconductors and anything connected to the massive build-out in computing infrastructure.
-
MyNest US Fund Jul 26
After spending a long period watching the artificial intelligence infrastructure build-out from the sidelines, we finally decided to join the party—albeit cautiously.
-
The SRS Fund Jun 2026
The month of Jun provided an important milestone in the Iran conflict. The agreement between the United States and Iran marked a significant step towards reducing geopolitical tension and reopening a clearer path for global energy flows
-
MyNest US Fund Jun 26
June was another remarkable month in the evolution of the global capitalism and the artificial intelligence investment cycle.
-
The SRS Fund May 2026
Korea, powered by the worldwide shortage and surge in memory demand, was hit directly by the AI wave, with its stock market more than doubling in a matter of 5 months. Taiwan, already the world’s most important advanced chip manufacturing hub has risen to become one of the largest stock market globally.
-
MyNest US Fund May 26
May has been an incredibly illuminating month for the MyNest US Fund. Looking across the broader landscape, the S&P 500 Index has continued its steady leg up, gaining +5.15% in the month of May alone to push its Year-to-Date (YTD) gain to +10.73%.
MYNEST.SG 